- Home
- RCKY vs CRBU Comparison
RCKY vs CRBU Comparison
Compare RCKY & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- CRBU
- Stock Information
- Founded
- RCKY 1932
- CRBU 2011
- Country
- RCKY United States
- CRBU United States
- Employees
- RCKY N/A
- CRBU N/A
- Industry
- RCKY Shoe Manufacturing
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- RCKY Consumer Discretionary
- CRBU Health Care
- Exchange
- RCKY Nasdaq
- CRBU Nasdaq
- Market Cap
- RCKY 196.3M
- CRBU 165.8M
- IPO Year
- RCKY 1993
- CRBU 2021
- Fundamental
- Price
- RCKY $30.55
- CRBU $1.83
- Analyst Decision
- RCKY Buy
- CRBU Strong Buy
- Analyst Count
- RCKY 1
- CRBU 3
- Target Price
- RCKY $40.00
- CRBU $6.67
- AVG Volume (30 Days)
- RCKY 54.6K
- CRBU 656.9K
- Earning Date
- RCKY 10-29-2025
- CRBU 11-05-2025
- Dividend Yield
- RCKY 2.08%
- CRBU N/A
- EPS Growth
- RCKY 24.23
- CRBU N/A
- EPS
- RCKY 2.48
- CRBU N/A
- Revenue
- RCKY $462,328,000.00
- CRBU $9,121,000.00
- Revenue This Year
- RCKY $7.02
- CRBU $9.23
- Revenue Next Year
- RCKY $3.96
- CRBU N/A
- P/E Ratio
- RCKY $12.05
- CRBU N/A
- Revenue Growth
- RCKY N/A
- CRBU N/A
- 52 Week Low
- RCKY $11.93
- CRBU $0.66
- 52 Week High
- RCKY $33.04
- CRBU $3.00
- Technical
- Relative Strength Index (RSI)
- RCKY 62.59
- CRBU 48.89
- Support Level
- RCKY $28.64
- CRBU $1.72
- Resistance Level
- RCKY $29.69
- CRBU $1.94
- Average True Range (ATR)
- RCKY 0.96
- CRBU 0.11
- MACD
- RCKY -0.10
- CRBU -0.01
- Stochastic Oscillator
- RCKY 97.09
- CRBU 45.39
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.